Living

European medicines regulator recommends approval for Novo's Wegovy pill

By Reuters Reuters
FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. REUTERS/Tom Little/File Photo
FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. REUTERS/Tom Little/File Photo Tom Little Reuters

The European Medicines Agency recommended approval for Novo Nordisk's weight-loss pill Wegovy, the regulator said on Friday, clearing its path to become the first oral weight loss drug in Europe, ahead of U.S. rival Eli Lilly.

(Reporting by Kunal Das and Puyaan Singh in Bengaluru)

Copyright Reuters or USA Today Network via Reuters Connect

This story was originally published May 22, 2026 at 6:47 AM.

Get unlimited digital access
#ReadLocal

Try 1 month for $1

CLAIM OFFER